首页> 外国专利> Unbiased Drug Selection for Audit Using Distributed Ledger Technology

Unbiased Drug Selection for Audit Using Distributed Ledger Technology

机译:使用分布式分类账技术的审计无偏见的药物选择

摘要

A computer-implemented method of auditing drug supply chain data gathered from a distributed ledger is disclosed. The method includes receiving a population of drug product records from the distributed ledger. The method includes receiving a first set of drug product criteria. The method includes determining a weighted probability for one or more drug product records of the population of drug product records. The method includes generating a randomized first subset of drug product records from the population of drug product records based on the weighted probability of the one or more drug product records. Other methods, systems, and the like for unbiased drug selection for audit are also disclosed.
机译:公开了一种计算机实现的审计药物供应链数据从分布分布的分区收集的审计药物供应链数据。 该方法包括从分布的分布槽接收药品记录的群。 该方法包括接收第一组药物产品标准。 该方法包括确定药品记录的一种或多种药物产品记录的加权概率。 该方法包括根据一种或多种药物产品记录的加权概率生成来自药品记录群的药品记录的随机化第一子集。 还公开了用于审计的非偏见药物选择的其他方法,系统等。

著录项

  • 公开/公告号US2021374184A1

    专利类型

  • 公开/公告日2021-12-02

    原文格式PDF

  • 申请/专利权人 OMNY INC.;

    申请/专利号US202117445118

  • 发明设计人 SEAN OBRIEN;

    申请日2021-08-16

  • 分类号G06F16/9035;H04L9/06;G06F17/18;

  • 国家 US

  • 入库时间 2022-08-24 22:34:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号